Evolocumab, a PCSK9 inhibitor, protects human endothelial cells against H2O2-induced oxidative stress
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evolocumab, a PCSK9 inhibitor, protects human endothelial cells against H2O2-induced oxidative stress
Authors
Keywords
-
Journal
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Volume -, Issue -, Pages 1-6
Publisher
Informa UK Limited
Online
2020-07-04
DOI
10.1080/13813455.2020.1788605
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytoprotective Role of Omentin Against Oxidative Stress-Induced Vascular Endothelial Cells Injury
- (2020) Nur Aqilah Binti Kamaruddin et al. MOLECULES
- PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
- (2019) Ji Soo Lee et al. Scientific Reports
- PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy
- (2018) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Roles of miR-4463 in H2O2-induced oxidative stress in human umbilical vein endothelial cells
- (2017) Xueqin Wang et al. Molecular Medicine Reports
- Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis
- (2017) Jiao Li et al. Molecular Medicine Reports
- Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up
- (2017) Dave L Dixon et al. Drug Design Development and Therapy
- Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies
- (2017) Xinyu Yang et al. Frontiers in Physiology
- Hemodynamic Shear Stress via ROS Modulates PCSK9 Expression in Human Vascular Endothelial and Smooth Muscle Cells and Along the Mouse Aorta
- (2015) Zufeng Ding et al. ANTIOXIDANTS & REDOX SIGNALING
- Cross-talk between LOX-1 and PCSK9 in vascular tissues
- (2015) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Improved biological activity of a single chain antibody fragment against human epidermal growth factor receptor 2 (HER2) expressed in the periplasm of Escherichia coli
- (2015) Vajihe Akbari et al. PROTEIN EXPRESSION AND PURIFICATION
- PCSK9 is Present in Human Cerebrospinal Fluid and is Maintained at Remarkably Constant Concentrations Throughout the Course of the Day
- (2014) Yan Q. Chen et al. LIPIDS
- The Multifaceted Proprotein Convertases: Their Unique, Redundant, Complementary, and Opposite Functions
- (2013) Nabil G. Seidah et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
- (2013) Daniel Urban et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Regulation of Epithelial Sodium Channel Trafficking by Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
- (2012) Vikas Sharotri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
- (2012) Paul M Ridker et al. LANCET
- Emerging role of high density lipoproteins as a player in the immune system
- (2011) Giuseppe Danilo Norata et al. ATHEROSCLEROSIS
- PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax–caspase9–caspase3 pathway
- (2011) Chun-Yan Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Propofol protects against hydrogen peroxide-induced oxidative stress and cell dysfunction in human umbilical vein endothelial cells
- (2009) Jiawei Chen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now